Document is current
Any future updates will be listed below
-
Authors
Wernike, Kerstin
Aebischer, Andrea
Audonnet, Jean-Christophe
Beer, Martin
-
Funding
Funding for this research was provided by:
Zoonoses Anticipation and Preparedness Initiative (IMI Grant Agreement no. 115760)
Friedrich-Loeffler-Institut, Bundesforschungsinstitut für Tiergesundheit
- License Information
-
More Information
Article History
Received: 11 April 2022
Accepted: 1 August 2022
First Online: 17 August 2022
Declarations
:
: Not applicable.
: Not applicable.
: J.-C.A. was an employee of Boehringer Ingelheim Animal Health France and K.W., A.A. and M.B. were involved in the development and testing of several vaccine preparations. K.W and M.B. are named as inventors in the patent application “Genomic sequences of schmallenberg virus and uses thereof”. This does not alter the adherence to the One Health Outlook policies on sharing information and data.
